Repare Therapeutics

IPO

Public · Montreal, Canada · Founded 2016 · $150.5M raised

Headquarters
Montreal
Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$150.5M
Last Round
$82.5M Series BSep 2019
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Repare Therapeutics was a Montreal, Quebec-based clinical-stage precision oncology company that used a proprietary synthetic lethality platform (SNIPRx) to discover and develop highly targeted cancer therapies for patients whose tumors harbor specific DNA damage repair deficiencies. The company's pipeline included PKMYT1 and ATR inhibitors targeting genomically defined patient populations. Repare formed major co-development partnerships with Roche and Bristol Myers Squibb. In late 2025, XOMA Royalty-backed XenoTherapeutics completed an acquisition of Repare Therapeutics.

Summary

Repare Therapeutics is a Biotech company based in Montreal, Canada, founded in 2016. It has raised $150.5M in total across 2 rounds, most recently a $82.5M Series B round in Sep 2019. Investors include Versant Ventures, Cowen Healthcare Investments and OrbiMed.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOJun 2020
$253.0M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Avenzo

Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...

San Diego, United States1–10Biotech, Oncology
Series BTotal funding$832.0MSep 2025
Bicycle TherapeuticsIPO

Novel bicyclic peptides and drug conjugates for cancer

Cambridge, United States201–500Biotech, Oncology
Private EquityTotal funding$607.0MJan 2024
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Repare Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/repare-therapeutics"><img src="https://indexed.vc/api/badge/company/repare-therapeutics" alt="Repare Therapeutics on Indexed.vc" width="260" height="76" /></a>